119 related articles for article (PubMed ID: 18319331)
1. Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.
Ding Y; Boguslawski EA; Berghuis BD; Young JJ; Zhang Z; Hardy K; Furge K; Kort E; Frankel AE; Hay RV; Resau JH; Duesbery NS
Mol Cancer Ther; 2008 Mar; 7(3):648-58. PubMed ID: 18319331
[TBL] [Abstract][Full Text] [Related]
2. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis.
Alfano RW; Leppla SH; Liu S; Bugge TH; Meininger CJ; Lairmore TC; Mulne AF; Davis SH; Duesbery NS; Frankel AE
Mol Cancer Res; 2009 Apr; 7(4):452-61. PubMed ID: 19372576
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.
Alfano RW; Leppla SH; Liu S; Bugge TH; Ortiz JM; Lairmore TC; Duesbery NS; Mitchell IC; Nwariaku F; Frankel AE
Mol Cancer Ther; 2010 Jan; 9(1):190-201. PubMed ID: 20053778
[TBL] [Abstract][Full Text] [Related]
6. Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
Bromberg-White JL; Boguslawski E; Hekman D; Kort E; Duesbery NS
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8979-92. PubMed ID: 21989728
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacy.
Alfano RW; Leppla SH; Liu S; Bugge TH; Duesbery NS; Frankel AE
Cell Cycle; 2008 Mar; 7(6):745-9. PubMed ID: 18245947
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin.
Bromberg-White JL; Boguslawski E; Duesbery NS
PLoS One; 2009 Sep; 4(9):e6956. PubMed ID: 19750016
[TBL] [Abstract][Full Text] [Related]
9. Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling.
Liu T; Milia E; Warburton RR; Hill NS; Gaestel M; Kayyali US
J Cell Physiol; 2012 Apr; 227(4):1438-45. PubMed ID: 21618534
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.
Ha SD; Reid C; Meshkibaf S; Kim SO
J Biol Chem; 2016 Apr; 291(16):8745-55. PubMed ID: 26912657
[TBL] [Abstract][Full Text] [Related]
11. Biological and biochemical characterization of anthrax lethal factor, a proteolytic inhibitor of MEK signaling pathways.
Bromberg-White JL; Duesbery NS
Methods Enzymol; 2008; 438():355-65. PubMed ID: 18413261
[TBL] [Abstract][Full Text] [Related]
12. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.
Duesbery NS; Resau J; Webb CP; Koochekpour S; Koo HM; Leppla SH; Vande Woude GF
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4089-94. PubMed ID: 11259649
[TBL] [Abstract][Full Text] [Related]
13. Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion.
Al-Dimassi S; Salloum G; Saykali B; Khoury O; Liu S; Leppla SH; Abi-Habib R; El-Sibai M
Int J Oncol; 2016 May; 48(5):1913-20. PubMed ID: 26984023
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death.
Ha SD; Ng D; Lamothe J; Valvano MA; Han J; Kim SO
J Biol Chem; 2007 Sep; 282(36):26275-83. PubMed ID: 17623653
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.
Khandia R; Pattnaik B; Rajukumar K; Pateriya A; Bhatia S; Murugkar H; Prakash A; Pradhan HK; Dhama K; Munjal A; Joshi SK
Oncotarget; 2017 May; 8(22):35835-35847. PubMed ID: 28415766
[TBL] [Abstract][Full Text] [Related]
16. Anthrax lethal toxin-induced lung injury and treatment by activating MK2.
Liu T; Warburton RR; Hill NS; Kayyali US
J Appl Physiol (1985); 2015 Aug; 119(4):412-9. PubMed ID: 26066827
[TBL] [Abstract][Full Text] [Related]
17. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2004 Mar; 378(Pt 2):569-77. PubMed ID: 14616089
[TBL] [Abstract][Full Text] [Related]
18. Effects of anthrax lethal toxin on human primary keratinocytes.
Koçer SS; Matic M; Ingrassia M; Walker SG; Roemer E; Licul G; Simon SR
J Appl Microbiol; 2008 Dec; 105(6):1756-67. PubMed ID: 19120626
[TBL] [Abstract][Full Text] [Related]
19. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
Lee CS; Dykema KJ; Hawkins DM; Cherba DM; Webb CP; Furge KA; Duesbery NS
PLoS One; 2011 Feb; 6(2):e17165. PubMed ID: 21365009
[TBL] [Abstract][Full Text] [Related]
20. BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin.
Abi-Habib RJ; Urieto JO; Liu S; Leppla SH; Duesbery NS; Frankel AE
Mol Cancer Ther; 2005 Sep; 4(9):1303-10. PubMed ID: 16170021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]